Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.

[1]  W. Shimizu,et al.  Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy　- Insights From the J-MINUET Study. , 2021, Circulation journal : official journal of the Japanese Circulation Society.

[2]  M. Jeong,et al.  Culprit-only versus multivessel or complete versus incomplete revascularization in patients with non-ST-segment elevation myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention using newer-generation drug-eluting stents. , 2020, Atherosclerosis.

[3]  L. Räber,et al.  Optimal Timing of Invasive Coronary Angiography following NSTEMI , 2020, Journal of interventional cardiology.

[4]  M. Jeong,et al.  Current status of acute myocardial infarction in Korea , 2018, The Korean journal of internal medicine.

[5]  M. Ferlini,et al.  Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent‐related complications in CKD patients, a systematic review, meta‐analysis and network meta‐analysis , 2018, Journal of interventional cardiology.

[6]  M. Jeong,et al.  Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock. , 2018, Journal of the American College of Cardiology.

[7]  E. Vicaut,et al.  Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials , 2017, The Lancet.

[8]  Shanti Patel,et al.  Representation and reporting of kidney disease in cerebrovascular disease: A systematic review of randomized controlled trials , 2017, PloS one.

[9]  G. Dehmer,et al.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, Ameri , 2017, Journal of the American College of Cardiology.

[10]  L. Boyer,et al.  Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis. , 2016, JACC. Cardiovascular interventions.

[11]  Ju Han Kim,et al.  Multicenter Cohort Study of Acute Myocardial Infarction in Korea　- Interim Analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[12]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[13]  G. Stone,et al.  Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[14]  U. Coşkun,et al.  The Relationship Between Chronic Kidney Disease and SYNTAX Score , 2011, Angiology.

[15]  L. Wallentin,et al.  Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register , 2010, Journal of internal medicine.

[16]  S. Pocock,et al.  Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. , 2010, Journal of the American College of Cardiology.

[17]  S. Yusuf,et al.  Early versus delayed invasive intervention in acute coronary syndromes. , 2009, The New England journal of medicine.

[18]  M. Jeong,et al.  Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2009, Circulation.

[19]  K. Eagle,et al.  Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. , 2009, American heart journal.

[20]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[21]  Seung‐Jung Park,et al.  Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. , 2005, Journal of the American College of Cardiology.

[22]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[23]  Jonathan C Craig,et al.  The number, quality, and coverage of randomized controlled trials in nephrology. , 2004, Journal of the American Society of Nephrology : JASN.

[24]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  E. Grech,et al.  Percutaneous coronary intervention. II: The procedure , 2003, BMJ : British Medical Journal.

[26]  C. Cannon,et al.  Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. , 2002, JAMA.

[27]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  H. Elming,et al.  Early Versus Standard Care Invasive Examination and Treatment of Patients with Non-ST-Segment Elevation Acute Coronary Syndrome:The VERDICT (Very EaRly vs Deferred Invasive evaluation using Computerized Tomography) - Randomized Controlled Trial , 2018 .

[29]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[30]  Baris Gencer,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2011 .

[31]  Deeb N Salem,et al.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.